PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Dingfu Biotarget Co., Ltd.

USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dingfu ranks #28,579 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.

#28,579
of 49,997 US assignees by volume
45th percentile
by Innovation Score (33.5/100)
7.2
avg claims per patent
+700%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28579 · Foreign Corporation #28,579 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #28,579/49,997
  • PHOTO-FINISH Diffusion Pharmaceut…
  • CPC-NARROW C07K · 5 areas
  • INNOV-THIN 33.5/100
  • CLAIMS-SPARSE 7.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +700% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Diffusion Pharmaceuticals LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dingfu’s 33.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Dingfu

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Dingfu's Innovation Score is 33.5/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Dingfu?

Each dot is one of Dingfu’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dingfu’s own 7.2 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Dingfu vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 510152025 Granted patents (volume) Avg claims / patent Diffusion Pharmaceuticals LLC - 9, 21.11Diffusion Pharmac…Digital Direct IR, Inc. - 9, 15Digital Direct IRDigital Metal AB - 9, 19.89Digital Metal ABDignity Sciences Limted - 9, 19.22Dignity Sciences…Documill OY - 9, 22Documill OYDongguan Apac Biotechnology Co., Ltd. - 9, 6.89Dongguan Apac Bio…Dongguan Silverlit Toys Co., Ltd - 9, 17.11Dongguan Silverli…Dongguan Tiger Point, Metal & Plastic Products Co., Ltd. - 9, 7Dongguan Tiger Po…Dingfu Biotarget Co., Ltd. - 9, 7.22Dingfu Biotarget
Dingfu vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dingfu's grants concentrate

Dingfu Biotarget Co., Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2019. By volume, Dingfu sits between Diffusion Pharmaceuticals LLC and Dongguan Tiger Point, Metal & Plastic Products Co., Ltd..

Dingfu's three-year grant acceleration

Dingfu Biotarget Co., Ltd. shows 6 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Dingfu's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Dingfu holds 9 patents at rank #28,547, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Dingfu

By rank, the assignees closest to #28,547 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Dingfu's primary technology class.

Dingfu's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 20192020202220232024 2
USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Dingfu Biotarget Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 11.1%
2020 2 22.2%
2022 2 22.2%
2023 2 22.2%
2024 2 22.2%

Which technologies does Dingfu Biotarget Co., Ltd. patent most?

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dingfu Biotarget Co., Ltd.'s patent record in context - here's where to go next.

  • Dingfu Biotarget Co., Ltd.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
  • Ranked #28,579 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Dingfu Biotarget Co., Ltd. against Diffusion Pharmaceuticals LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.